RESULTS METHODS Pre-exposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child P. Vernazza 1 I. Brenner 1, I. Graf.

Slides:



Advertisements
Similar presentations
HIV Counselling and Testing
Advertisements

Dr. Zhao TCM Help Infertility
Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.
Cristin Muecke, RMOH Nick Scott, ED AIDS NB.  Why HIV testing remains important  Treatment as prevention  Discuss advantages/disadvantages of various.
Genital Herpes Prevention and Clinical Services: What Should Health Departments Do Now? H. Hunter Handsfield, M.D. University of Washington Public Health.
Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Condom Effectiveness A presentation developed by PSI-TANZANIA, Tanzania Bureau of Standards and TGPSH/GTZ.
Infertility in General Practice Kate Hooks ST2 GP.
Introduction to HIV Discordant Couple Insemination Deborah J. Anderson, Ph.D. Dept Medicine and Center for AIDS Research Harvard Medical School and Department.
European clinical experience with assisted reproductive technology in HIV-discordant couples
Assisted Reproductive Technology in Resource-Poor Settings Arlene D. Bardeguez, MD, MPH Dept. of Obstetrics, Gynecology & Women’s Health New Jersey Medical.
PMTCT of HIV- Dr Abhimanyu Makane MBBS CHIV FHM(CMC,Vellore) AAHIVS Consultant HIV Physician Sterling Multispecialty Hospial,Nigdi,Pune.
Infertility 101 Dana Ambler, DO Director, Donor Egg Program Associate Physician Conceptions Reproductive Associates.
Standard Days Method Advanced Slides 1. Efficacy Study of SDM Multi-site prospective study Services provided in existing programs Clients were followed.
John Odero Ong’ech MBChB,MMed(Ob/Gyn),MPH Kenyatta National Hospital-University of Nairobi, Kenya Presentation at XIX International AIDS Conference in.
Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma Marcelin AG 1, Tubiana R 1, Lambert-Niclot.
Bio 27 November 7, 2012 Chapter 11: Conception, Pregnancy, and Childbirth.
Safer Conception for Sero-Discordant Couples Judy Levison, MD, MPH Associate Professor, Departments of Obstetrics and Gynecology and Family and Community.
Optimal timing of IUI Tansu KÜÇÜK GATA ANKARA. Cx Px.
Assisted Reproduction Among HIV Sero-Discordant Couples
HIV/AIDS Presented by Kunphen center for substance dependence and HIV/AIDS.
What is Assisted Reproduction Technology? Jessica Guerrero.
Benefits of PrEP as an adjunctive method of HIV prevention during attempted conception between HIV-uninfected women and HIV- infected male partners: A.
Grade 8 Topic 3 Pregnancy Prevention. When making a decision… Be aware of all possible consequences Consider how to prevent these consequences Make a.
Infertility Parenting. What is Infertility? n Not being able to get pregnant after at least one year of trying. n Women who are able to get pregnant but.
ESHRE 26th Annual Meeting,Rome.
HIV & Subfertility Leila C G Frodsham Clinical Research Fellow Assisted Conception Unit Chelsea and Westminster Talk to UK-CAB (UK-Community Advisory Board)
I SIMPOSIO INTERNACIONAL de REPRODUCCION y HIV CONCEPTS AND DATA FOR THE PRESS Dr Augusto E Semprini University of Milan & University College of London.
Willingness to use HIV prevention strategies to conceive with an HIV-positive partner: opinions from HIV-negative women in serodifferent relationships.
So what is the problem? Michael Savvas Assisted Conception Unit King’s College Hospital.
1 INFERTILITY 1. Definitions Under 35 yoNo conception after one year of unprotected intercourse Over 35 yoNo conception after 6 months of unprotected.
Washington D.C., USA, July 2012www.aids2012.org Pregnancy and HIV Acquisition Nelly Mugo Kenyatta National Hospital/ University of Washington Hormonal.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
Conceiving Children © Robert J. Atkins, Ph.D.. When am I most fertile?  Fertility peaks around 20 – 24 years.
10 facts about AIDS Source: World Health Organization
Antiretroviral resistance is not an important risk of the oral tenofovir prophylaxis trial in Botswana: a simple mathematical modeling approach Dawn K.
Infertility Issues, Causes & TreatmentIssues, Causes & Treatment.
PRECONCEPTION COUNSELING AND CARE FOR HIV-INFECTED WOMEN OF CHILDBEARING AGE.
Reproductive Choice and Family Planning for Persons Living with HIV/AIDS Jennifer Marshall Assistant Director.
Risk of Sexual Transmission under HAART Background information on Swiss statement Pietro Vernazza President EKAF- Swiss Federal Commission on AIDS.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Pre-exposure Prophylaxis for HIV Prevention Efficacy and the importance of adherence Joanne Stekler,
Grinsztejn B, et al, Lancet Infect Dis, March 4 th 2014 PRIMARY COMBINED M&M OUTCOME FIRST AIDS DEFINING EVENT FIRST TB EVENT DEATH.
Washington D.C., USA, July 2012www.aids2012.org Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples: a systematic.
NYC DOHMH BSTDC School-Based Education, Screening and Treatment Pilot Program Meighan Rogers, MPH Bureau of STD Control, NYC DOHMH Region II IPP Meeting,
New Developments in HIV Kerri Howley Coordinator – The Green Room
Ceri Evans Senior Sexual Health Adviser West London Centre for Sexual Health Chelsea and Westminster Hospital Foundation Trust.
Conceiving Children. Women’s fertility  Peaks around 20 – 24 years.
الدكتورة زينب عبد الكاظم فتنان شهاده الدبلوم العالي في الامراض النسائية والتوليد والعقم شهادة البورد ( الدكتوراة ) في النسائية والتوليد والعقم بكلوريوس.
HIV and Women Collaborating Across Borders to Advance the Health of Women IAS 2012 Gina M. Brown, M.D. July 22, 2012.
BIOTECHNOLOGY. Biotechnology is a series of technologies related to living organisms. Using microorganisms, like bacteria and cells, scientists can develop.
Understanding the Rationale of the 2015 WHO Guidelines on PrEP IAS Satellite Session Heather Watts M.D. Office of the Global AIDS Coordinator July 18,
Pre-exposure Prophylaxis (PrEP) for HIV Prevention: What’s the Future? Joanne Stekler, MD MPH Assistant Professor of Medicine University of Washington.
#AIDS2016 Safer conception for men and women living with HIV and their partners Key issues and considerations for widespread implementation.
Supporting HIV-affected Women and Men to Safely Meet Reproductive Goals: Insights into Contraception, Safer Conception, and Infertility Prevalence, consequences.
Module 4 (e) Pregnancy and Breast Feeding
“Its Different Now”: The Changing Landscape of HIV testing
Conceiving Children.
On Demand PrEP for Men at High Risk for HIV IPERGAY
Reproductive Choice and Family Planning for Persons Living with HIV/AIDS Jennifer Marshall Assistant Director
Assisted reproduction and obstetrics
Infertility Parenting.
ASSISTED REPRODUCTION
Prescribing PrEP to adolescents and young adults
Safer Conception for Sero-Discordant Couples
PrEP.
Analytic framework illustrating exposure to preventive measures that reduce the risk of transmission between HIV-serodiscordant sex partners. Analytic.
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

RESULTS METHODS Pre-exposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child P. Vernazza 1 I. Brenner 1, I. Graf 2 1 Division of Infectious Diseases and 2 Social Services, Cantonal Hospital St. Gallen, Switzerland MoPDC01 BACKGROUND 4 th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 2007, Sydney, Australia Twenty-two couples were counselled at one centre from March 2004 to March 2007 and opted for the alternative program with timed unprotected intercourse and TDF-PREP The average time for one counselling was 60 minutes. All male partners have been on antiretroviral therapy with suppressed HIV-RNA ( 3 months. All female partners were tested HIV-negative 3 months after the last unprotected intercourse More than 70% of all women became pregnant, 50% after up to 3 episodes of unprotected intercourse HIV discordant couples were counselled about the minimal risk of transmission during unprotected sex (4). An alternative method of timed unprotected intercourse with pre-exposure-prophylaxis (PREP) with tenofovir (TDF) was discussed with all couples HIV-RNA in semen was only tested in the beginning of the program but was always undetectable. All couples were tested or treated for asymptomatic chlamydia infection Urine LH-testing was used for the timing of ovulation First dose TDF was given the morning of Urine-LH- peak, the second dose next morning and unprotected sex timed the evening after the second dose. CONCLUSION Objectives: To reduce risk-taking behavior in HIV-discordant couples (male HIV-pos.) willing to conceive a child. Methods: HIV-discordant couples expressing the desire to conceive a child received a standardized risk reduction counseling including LH-peak measurement and pre-exposure prophylaxis with tenofovir 36 and 12 h before intercourse. Couples were either included after having previously been counseled for artificial insemination with processed semen and quit the program for any reason or after referral through their HIV-physician. Results: Twenty-two couples were admitted for risk reduction counseling. All male partners have been under a fully suppressive antiretroviral treatment. Six couples admitted that they had previously tried to conceive by unprotected intercourse. Twenty-one couples decided to use the proposed risk reduction strategy with timed intercourse and TDF-pre-exposure-prophylaxis. Pregnancy rates were high with more than 50% pregnancies achieved after 3 cycles (11/21). In 15/21 female partners got pregnant after up to 10 attempts. All women tested negative for HIV-antibodies 3 months after the last exposure. Conclusions: The true number of HIV-discordant couples who practice unprotected sex to conceive is most likely underestimated. The risk of transmission in a couple with a fully treated male partner is low and can further be reduced by timed intercourse and a short pre-exposure prophylaxis with tenofovir. The pregnancy rates of natural conception are substantially higher than with artificial reproduction techniques (40% in our program). ABSTRACT Approximately half of all HIV-discordant couples express the desire to conceive a child (1) References P. Vernazza, MD, KSSG, 9007 St. Gallen, Switzerland Fax: Contact information 1.Panozzo et al, SMW 2003;133:124–127 2.Bujan et al, AIDS 2007 in press 3.Savasi et al, Hum. Reprod, 2007; 22: Vernazza et al, AIDS. 2006;20:635-6 Several European centers in reproduction offer insemination with processed semen (2). Most services apply a density gradient centri- fugation followed by swim-up of motile sperm (Fig.) Pregnancy rates of the different programs vary by method from 40% following intrauterine insemination (IUI) to 70% by in-vitro fertilization(3). Approximately one third of the couples who contact an insemination centre do not start the procedure. Half of those conceive a child by unprotected intercourse (4). Fig 2: Pregnancy rates after unprotected intercourse Given the minimal risk of transmission of HIV during fully supressive ART, timed unprotected intercourse could be a reasonable alternative to in vitro methods. Pre-exposure prophylaxes with 2 doses of tenofovir to further reduce the minimal risk is well accepted Not surprisingly, pregnancy rates are signif. higher after natural intercourse than after artificial insemination Alternative methods for safe conception in HIV-discor- dant couples should be further evaluated